本页面由Tiger Trade Technology Pte. Ltd.提供服务

Salarius Pharmaceuticals Inc

0.8400
0.0000
成交量:- -
成交额:468.84万
市值:536.27万
市盈率:-0.02
高:0.8400
开:0.8400
低:0.8400
收:0.8400
52周最高:108.00
52周最低:0.5148
股本:638.42万
流通股本:634.18万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-39.1909
每股收益(LYR):-86.9214
净资产收益率:-139.55%
总资产收益率:-69.91%
市净率:1.26
市盈率(LYR):-0.01

数据加载中...

2025/08/22

重要事件披露

Form 8-K - Current report
2025/08/18

重要事件披露

Form 8-K - Current report
2025/08/15

重要事件披露

Form 8-K - Current report
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/08/06

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/07/31

重要事件披露

Form 8-K - Current report
2025/07/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/28

重要事件披露

Form 8-K - Current report
2025/07/21

重要事件披露

Form 8-K - Current report
2025/07/14

重要事件披露

Form 8-K - Current report
2025/07/08

重要事件披露

Form 8-K - Current report
2025/06/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/06/16

重要事件披露

Form 8-K - Current report
2025/06/11

重要事件披露

Form 8-K - Current report
2025/05/22

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/25

重要事件披露

Form 8-K - Current report
2025/04/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]